Sputnik V import: India in price talks, DRL to import initial doses after regulatory nod
SECTIONS
Share
Synopsis
Dr Reddy’s Laboratories has a tie-up with the Russian Direct Investment Fund, which backed the development of Sputnik V, and will import the initial doses of the vaccine once it gets approval from the drug regulator. Subsequent doses of the vaccine will be manufactured in India.
Agencies
Sputnik V’s efficacy is confirmed at 91.6% and it is one of three vaccines with an efficacy of over 90%.
The government is negotiating the price at which it will procure imported doses of Russia’s Covid-19 vaccine Sputnik V, which is at an advanced stage of the regulatory approval process in India.
Last Updated:
EU Members in Talks Privately For Sputnik V, Demand Rising: Russia s RT To Republic
Roman Kosarev, the Presenter and correspondent on Russia Today (RT) TV channel acknowledged the issues of Russia’s Sputnik V COVID-19 vaccine approval in the EU
Image credits: AP
In an exclusive interview with Republic s Executive Editor Niranjan Narayanaswamy, Roman Kosarev, the Presenter and correspondent on Russia Today (RT) TV channel acknowledged the issue of Russia’s Sputnik V COVID-19 vaccine approval in the European Union. While answering a question, Kosarev noted that the EU taking a long time to approve the Russia-made vaccine has prompted different responses throughout Europe as well. He noted that Germany, Austria, Italy that are EU member states are already in talks “privately” to bring the Sputnik V from Russia to their respective countries.
Despite the pandemic-related challenges, Russia progresses with vaccination at home and abroad pressenza.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pressenza.com Daily Mail and Mail on Sunday newspapers.
Tuesday, 02 Mar 2021 07:56 PM MYT
BY SOO WERN JUN
A dose of the Pfizer-BioTech Covid-19 vaccine is pictured at the UiTM Hospital in Sungai Buloh March 2, 2021. ― Picture by Hari Anggara
Subscribe to our Telegram channel for the latest updates on news you need to know.
KUALA LUMPUR, March 2 Malaysia’s Drug Control Authority has today agreed to grant several Covid-19 vaccines conditional registration for use during disaster, Health director-general Tan Sri Dr Noor Hisham Abdullah said.
In a statement, Dr Noor Hisham, said the Covid-19 vaccines are as follows:
1. Covid-19 Vaccine AstraZeneca Solution for Injection
Registration holder: AstraZeneca Sdn. Bhd.
Manufacturer: Medimmune Pharma BV Netherland
PUTRAJAYA: The Drug Control Authority (DCA), in a meeting today, granted conditional approval to three Covid-19 vaccines for use to curb the spread of.